SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Zebra 365 who wrote (5933)3/17/1998 10:37:00 AM
From: Don Dunlap  Read Replies (1) of 23519
 
Zebra, I understand that the revenue is recognized when the product is shipped. Perhaps VVUS is expensing costs of inventory (or cost of goods sold) at production. I believe they did this before they received the original FDA approval. That is one reason margins were so high wit the initial product. The costs of producing the product had been recognized several quarters earlier.

However, I don't believe VVUS must recognize productions costs when the product is produced. Blankind is an accountant and said the costs would show up in inventory. When the product is shipped, VVUS could then recognize the cost of inventory against their income.

The question to blankmind is: Does VVUS recognize production cost at the time of production or at the time the product is shipped?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News